Deep Intelligence Across Industries

Company Headquarter: Ontario, Canada Founded: 2013 Workforce: ~1800 Company Working: Tilray Brands, Inc. (Tilray) engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The company is focusing on medical cannabis research, cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: cannabis and hemp. The cannabis segment sales consist of adult-use, medical, and bulk sales of cannabis under-regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to the patient. The hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD sold in an unlicensed operation and sold to retail, wholesale, and direct to consumers. It is a GMP-certified medical cannabis producer, which supplies cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments, and researchers on five continents. Its subsidiaries include Manitoba Harvest (Canada), High Park Company (Canada), Tilray Australia & New Zealand, Tilray Canada, Tilray Europe, and Tilray Latin Americas. In 2018, the company created a Medical Advisory Board, which guides its clinical trial selection process and product development initiatives. It has seven production and processing facilities, including one in Portugal, three cultivation sites in Ontario & British Columbia, and three processing facilities in Manitoba & Ontario. In May 2021, Tilray and Aphria Inc. (Canada) announced their merger in an all-stock deal. The company is directly present in more than 10 countries and has a strong presence in all the established markets such as North Americas, Europe, Africa, and Australia. It also focuses on the research and development of innovative products and spends a significant amount of revenue on R&D

Company Headquarter: Nevada, US Founded: 2005 Workforce: ~50 Company Working: Cannabis Sativa, Inc. has operations in three divisions: telemedicine, contrast manufacturing, and brand development & marketing of products and services in the CBD and marijuana industries. It operates through its subsidiaries, including Wild Earth Naturals (US), White Rabbit (India), hi Brands International (US), Presto Doctor (US), and iBudtender (Canada). It offers products and services to both businesses and consumers and is a publicly-traded company listed as OTCQB: CBDS. The company’s main operations run through its 51% owned telehealth subsidiary PrestoDoctor. PrestoDoctor is a proprietary online telemedicine platform that gives customers access to physicians to obtain a recommendation for medical marijuana.

Company Headquarters: UK, Europe Founded: 2013 Workforce: 500 Company Working: BenevolentAI is a clinical-stage AI-enabled drug discovery and development company. Through the combined capabilities of its AI platform, scientific expertise, and web-lab facilities, Benevolent AI is well-established to deliver novel drug candidates with a higher probability of clinical success. Moreover, BenevolentAI powers a growing in-house pipeline of 13 named drug programmers, and it maintains collaboration with AstraZeneca (UK), as well as research and charitable institutions. The company offers its services under the category of pipeline, COVID-19, atopic dermatitis, and ulcerative colitis as well as company has a strong market presence in Europe.

Company Headquarters: Toronto, Canada Founded: 2013 Workforce: 200 Company Working: Cyclica is a data-driven drug discovery company. The company’s calculation method for polypharmacology is unique in the industry. Cyclica used a proteome-wide lens to measure novel and off-target interaction instantaneously. The company offers its product and services under the category of drug development, network pharmacology, drug repositioning, proteomics, clinical trials, side effects, bioinformatics, systems biology, drug discovery, artificial intelligence, polypharmacology, medicines, machine learning, pharmacology, pharmaceuticals, and bioinformatics. The company has a strong business presence in Canada.

Company Headquarters: Hong Kong, China Founded: 2014 Workforce: 200 Company Working: Insilico Medicine is a technology company specializing in drug discovery and drug development processes. It offers products under the category of pharma.AI suite, pandaomics, chemistry42, and inclinico. The company is dedicated to expanding human productive longevity and transforming every step of the drug discovery and drug development process by best practices in biomarker discovery, drug development, digital medicine, and aging research. The company has a strong business presence in the US, China, Canada, UAE, Belgium, the UK, and Taiwan.

Company Headquarters: North Carolina, US Founded: 2009 Workforce: ~500 Company Working: Cloud Pharmaceuticals is a leader in the emerging field of artificial intelligence-based drug development. It is currently researching new medications at the clinical stage. The company works with the pharmaceutical, biotechnology, and medical research industries to develop, generate, and provide licenses for cutting-edge medicinal molecules for a range of medical purposes. Additionally, it produces innovative medications through vertical holdings, frequently LLCs for certain therapeutic areas.

Company Headquarters: Ontario, Canada Founded: 2015 Workforce: ~200 Company Working: Deep Genomics is a biotechnology company that builds proprietary Artificial Intelligence (AI) and uses it to discover new ways to correct the effects of genetic mutations and develop personalized therapies for individuals with rare Mendelian and complex diseases. It offers cell and molecular biology, clinical development, molecular genetics, organic chemistry, preclinical development, and other solutions. The company's AI platform generates billions of data points using throughput assays and sophisticated robotics systems and creates dozens of engineered and validated machine learning systems to support drug development. This allows researchers to categorize, rank, interpret, and link genetic variants, whether they are therapeutic or natural. Furthermore, Deep Genomics serves customers in Canada.

Company Headquarters: California, US Founded: 2012 Workforce: ~ 63 Company Working: Atomwise Inc. (Atomwise) a creative pharmaceutical company, is revolutionizing the search for small-molecule drugs by utilizing AI. The platform for AI-based, structure-based drug development is offered by Atomwise. Deep learning neural networks are used by Atomwise to find new medications. The company achieved the highest outcomes in the world for toxicity detection, binding affinity prediction, and the development of novel pharmacological hits. With three lead-optimization efforts and more than 30 discovery programs, Atomwise is building a wholly owned pipeline of small-molecule pharmaceutical prospects. Additionally, the Bill and Melinda Gates Foundation (US) awarded the company a 2.3 USD million grant in 2020 to support the creation of numerous global health initiatives that will advance cutting-edge antimalarial and anti-tuberculosis small molecule therapies in conjunction with the foundation's extensive network. In addition, Atomwise predicts drug candidates for pharmaceutical companies, start-ups, and research institutions. It is currently using computational drug design to design drugs against COVID-19. The company operates in California US.

Company Headquarters: Utah, US Founded: 1979 Workforce: ~5,000 Company Working: Cotiviti, Inc. is a leading solution and analytics company focusing on improving customers' financial and quality performance. The company provides solutions for payers, government agencies, healthcare providers, retailers, employers, brokers, and TPAs. It provides solutions including payment accuracy, risk adjustment, quality and performance, and consumer engagement. The company works with more than 180 healthcare payers. It provides payment accuracy solutions primarily to healthcare organizations. It provides audit and recovery services to the retail industry. It has a presence in the US, Canada, India, and Nepal.